The influence of oral combined oral contraceptive with estradiol valerate and dienogest  on hemostatic system (a review)

O. R. Grigoryan; Е. Н. Андреева

doi:10.17116/repro201521214-17

The influence of oral combined oral contraceptive with estradiol valerate and dienogest on hemostatic system (a review)

O. R. Grigoryan, Е. Н. Андреева

In: Problemy reproduktsii · 2015 · vol. 21(2) , pp. 14 · doi:10.17116/repro201521214-17 · W2318593681

OA: bronze CC0

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This review examines the influence of oral combined oral contraceptives containing estradiol valerate and dienogest on the hemostatic system.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (18)

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex
Effect of four oral contraceptives on hemostatic parameters via openalex
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study via openalex
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe via openalex
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature via openalex
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial via openalex
W2616068419 via openalex
doi:10.1016/0378-5122(89)90251-x via openalex
doi:10.1055/s-0038-1646528 via openalex
doi:10.1016/j.contraception.2005.09.015 via openalex
doi:10.1046/j.1365-2141.1997.192707.x via openalex
doi:10.1542/peds.2010-2221 via openalex
doi:10.3109/00016348209155333 via openalex
doi:10.2165/11591200-000000000-00000 via openalex
doi:10.1016/j.contraception.2008.05.004 via openalex
doi:10.1016/j.ogc.2006.05.003 via openalex
doi:10.1111/j.1365-2141.2007.06973.x via openalex
doi:10.1016/0002-9378(82)90218-6 via openalex

Source provenance

openalex: last seen: 2026-05-10T11:08:07.918008+00:00

License: CC0 · commercial use OK

[1] Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex

[2] Effect of four oral contraceptives on hemostatic parameters via openalex

[3] Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study via openalex

[4] Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe via openalex

[5] Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature via openalex

[6] Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial via openalex

[7] W2616068419 via openalex

[8] doi:10.1016/0378-5122(89)90251-x via openalex

[9] doi:10.1055/s-0038-1646528 via openalex

[10] doi:10.1016/j.contraception.2005.09.015 via openalex

[11] doi:10.1046/j.1365-2141.1997.192707.x via openalex

[12] doi:10.1542/peds.2010-2221 via openalex

[13] doi:10.3109/00016348209155333 via openalex

[14] doi:10.2165/11591200-000000000-00000 via openalex

[15] doi:10.1016/j.contraception.2008.05.004 via openalex

[16] doi:10.1016/j.ogc.2006.05.003 via openalex

[17] doi:10.1111/j.1365-2141.2007.06973.x via openalex

[18] doi:10.1016/0002-9378(82)90218-6 via openalex